A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future

Olanzapine is a second-generation atypical antipsychotic with proven efficacy for the treatment of schizophrenia. Approved in 1996, olanzapine is one of the most studied antipsychotics, resulting in a considerable amount of clinical data across diverse patient populations. Despite the fact that olan...

Descripción completa

Detalles Bibliográficos
Autores principales: Citrome, Leslie, McEvoy, Joseph P, Todtenkopf, Mark S, McDonnell, David, Weiden, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733343/
https://www.ncbi.nlm.nih.gov/pubmed/31564881
http://dx.doi.org/10.2147/NDT.S209284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733343/
https://www.ncbi.nlm.nih.gov/pubmed/31564881
http://dx.doi.org/10.2147/NDT.S209284

Ejemplares similares